Table 1. Demographic, clinical characteristics and laboratory findings and outcomes of the entire cohort of patients.
| Total number of patients = 227 | |
|---|---|
| Age years (mean±SD) | 72±13 |
| Age> 70 years, n (%) | 127 (57) |
| Male gender, n (%) | 129 (56.8) |
| Clinical features | |
| Hypertension, n (%) | 129 (56.8) |
| Cardiovascular disease, n (%) | 77 (33.9) |
| Diabetes, n (%) | 55 (24.2) |
| COPD, n (%) | 37 (16.2) |
| Obesity (BMI>30 Kg/m2), n (%) | 25 (11) |
| Cancer, n (%) | 20 (8.8) |
| Main laboratory findings | |
| Platelet count, 109/L (mean±SD) | 220567±96698 |
| White Blood Cell, 109/L (mean±SD) | 8.78±11.87 |
| Creatinine, mg/dL (mean±SD) | 1.33±1.29 |
| PT, activity % (mean±SD) | 72.3±15.5 |
| aPTT, seconds (mean±SD) | 36.6±45.1 |
| Fibrinogen, mg/dL (mean±SD) | 599±166 |
| C reactive protein, mg/L, (median—IQR) | 16.5 (6.7–56.5) |
| D-dimer value on admission, ng/mL (median–IQR) | 1483 (576–7732) |
| D-dimer peak value, ng/mL (median—IQR) | 1865 (1046–5682) |
| D-dimer peak value 1st quartile, ng/mL | < 1046 |
| D-dimer peak value 2nd quartile, ng/mL | 1046–1865 |
| D-dimer peak value 3rd quartile, ng/mL | 1866–5682 |
| D-dimer peak value 4th quartile, ng/mL | >5682 |
| Padua Prediction Score | |
| 5, n (%) | 79 (34.8) |
| 6, n (%) | 119 (52.4) |
| >6, n (%) | 29 (12.8) |
| Mean±SD | 5.91±1.0 |
| Diagnosis of DVT | |
| Total, n (%) | 31 (13.7) |
| Proximal, n (%) | 14 (6.2) |
| Distal, n (%) | 17 (7.5) |
| Timing of DVT diagnosis since admission | |
| Day 0–3, n (%) | 18 (58.1) |
| Day 5–8, n (%) | 11 (35.5) |
| Day 12–15, n (%) | 2 (6.4) |
| Outcome measures | |
| In-hospital length of stay, days (mean±SD) | 12.2±6.7 |
| Step up to ICU, n (%) | 12 (5.3) |
| In-hospital death, n (%) | 22 (9.7) |
| Step up to ICU or in-hospital death, n (%) | 34 (15) |
COPD: Chronic obstructive pulmonary disease; PT: prothrombin time; aPTT: activated partial thromboplastin time; DVT: deep vein thrombosis; ICU: Intensive Care Unit.